REVY Trademark

Trademark Overview


On Wednesday, December 6, 2023, a trademark application was filed for REVY with the United States Patent and Trademark Office. The USPTO has given the REVY trademark a serial number of 98301441. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, July 12, 2024. The REVY trademark is filed in the Pharmaceutical Products category with the following description:

Nutritional supplements; Powdered nutritional supplement drink mix; Protein dietary supplements; Protein supplements
revy

General Information


Serial Number98301441
Word MarkREVY
Filing DateWednesday, December 6, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, July 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesNutritional supplements; Powdered nutritional supplement drink mix; Protein dietary supplements; Protein supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressPark Ridge, IL 60068

Trademark Events


Event DateEvent Description
Wednesday, December 6, 2023NEW APPLICATION ENTERED
Sunday, March 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2024NON-FINAL ACTION E-MAILED
Friday, July 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 12, 2024NON-FINAL ACTION WRITTEN
Friday, July 5, 2024ASSIGNED TO EXAMINER